Apellis Pharmaceuticals to Host a Fireside Chat at the 6th Annual Evercore ISI HealthCONx Conference
21 Noviembre 2023 - 6:00AM
Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), today announced
that the company will host a fireside chat at the 6th Annual
Evercore ISI HealthCONx Conference on Tuesday, November 28, 2023,
at 10:00 a.m. ET.
The event will be available via a live webcast from the “Events
and Presentations” page of the “Investors and Media” section of the
company’s website. A replay of the webcast will be available for
approximately 90 days following the event.
About Apellis Apellis Pharmaceuticals,
Inc. is a global biopharmaceutical company that combines courageous
science and compassion to develop life-changing therapies for some
of the most challenging diseases patients face. We ushered in the
first new class of complement medicine in 15 years and now have two
approved medicines targeting C3. These include the first-ever
therapy for geographic atrophy, a leading cause of blindness around
the world. We believe we have only begun to unlock the potential of
targeting C3 across serious retinal, rare, and neurological
diseases. For more information, please
visit http://apellis.com or follow us
on Twitter and LinkedIn.
Investor Contact:Meredith
Kayameredith.kaya@apellis.com617.599.8178
Apellis Pharmaceuticals (NASDAQ:APLS)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Apellis Pharmaceuticals (NASDAQ:APLS)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024